UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction ...

HCA Healthcare, Inc. (NYSE:HCA) Q2 2022 Earnings Conference Call July 22, 2022 9:00 AM ET Company Participants Frank Morgan - Vice President, Investor Relations Samuel Hazen - Chief Executive Officer William Rutherford - Executive Vice President and Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Ann Hynes - Mizuho Securities Whit Mayo - SVB Securities Gary Taylor - Cowen Joanna Gajuk - Bank of America Justin Lake - Wolfe Research Ben Hendrix - ...

HCA Healthcare, Inc. (NYSE:HCA) Q1 2022 Results Conference Call April 22, 2022 10:00 AM ET Company Participants Sam Hazen - Chief Executive Officer Bill Rutherford - Executive Vice President & Chief Financial Officer Frank Morgan - VP, Investor Relations Conference Call Participants A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Whit Mayo - SVB Securities Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Gary Taylor - Cowen Brian T ...

Table of Contents Index to Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in ...

HCA Healthcare, Inc. (NYSE:HCA) Q4 2021 Earnings Conference Call January 27, 2022 10:00 AM ET Company Participants Mark Kimbrough - Vice President, Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Executive Vice President & Chief Financial Officer Michael Cuffe - Chief Medical Officer Frank Morgan - VP, Investor Relations Conference Call Participants Ann Hynes - Mizuho Securities Kevin Fischbeck - Bank of America Andrew Mok - UBS Technology Justin Lake - Wolfe Research A.J. Rice - Cr ...

Table of Contents Commission file number 1-11239 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Registrant's telephone number, including area code) Not Applicable (Former name, fo ...

HCA Healthcare, Inc. (NYSE:HCA) Q3 2021 Earnings Conference Call October 22, 2021 10:00 AM ET Company Participants Mark Kimbrough - VP, IR Sam Hazen - CEO Bill Rutherford - EVP and CFO Conference Call Participants Kevin Fischbeck - Bank of America Ann Hynes - Mizuho Securities Brian Tanquilut - Jefferies Justin Lake - Wolfe Research Scott Fidel - Stephens Ralph Giacobbe - Citi Frank Morgan - RBC Capital Markets Pito Chickering - Deutsche Bank Whit Mayo - SVB Leerink Lance Wilkes - Bernstein Jamie Perse - Go ...

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3 ...

HCA Healthcare, Inc. (NYSE:HCA) Q2 2021 Earnings Conference Call July 20, 2021 10:00 AM ET Company Participants Sam Hazen - CEO Bill Rutherford - EVP and CFO Mark Kimbrough - VP, IR Conference Call Participants Brian Tanquilut - Jefferies Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Scott Fidel - Stephens Ralph Giacobbe - Citi Joshua Raskin - Nephron Research Jamie Perse - Goldman Sachs Lance Wilkes - Bernstein Operator Hello, and w ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) For the quarterly period ended March 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction of incorporation or organization) One Park Plaza Nashville, Tennessee 3 ...